319 related articles for article (PubMed ID: 17151288)
21. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
[TBL] [Abstract][Full Text] [Related]
22. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
[TBL] [Abstract][Full Text] [Related]
23. Differential anti-thrombotic benefit and bleeding risk profiles of antagonists of protease-activated receptor 1 and 4 in Cynomolgus Macaques.
Wickham LA; Sitko G; Stranieri-Michener M; Handt L; Basso A; Fried S; Chu L; Maderia M; Owens K; Castriota G; Chen Z; Metzger JM; Imbriglio J; Wang X; Cai TQ
Thromb Res; 2016 Sep; 145():133-9. PubMed ID: 27318768
[TBL] [Abstract][Full Text] [Related]
24. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
[TBL] [Abstract][Full Text] [Related]
25. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
27. Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells.
Mollinedo F; Gajate C; Flores I
J Immunol; 1994 Sep; 153(6):2457-69. PubMed ID: 8077660
[TBL] [Abstract][Full Text] [Related]
28. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
29. C1-inhibitor influence on platelet activation by thrombin receptors agonists.
Tarandovskiy ID; Buehler PW; Karnaukhova E
Clin Appl Thromb Hemost; 2022; 28():10760296221120422. PubMed ID: 35996317
[TBL] [Abstract][Full Text] [Related]
30. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
31. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptors in cardiovascular diseases.
Leger AJ; Covic L; Kuliopulos A
Circulation; 2006 Sep; 114(10):1070-7. PubMed ID: 16952995
[TBL] [Abstract][Full Text] [Related]
33. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
[TBL] [Abstract][Full Text] [Related]
34. Oligosaccharide Blocks PAR1 (Proteinase-Activated Receptor 1)-PAR4-Mediated Platelet Activation by Binding to Thrombin Exosite II and Impairs Thrombosis.
Li S; Wang W; Lin L; Yang L; Cai Y; Yang X; Zhang T; Xiao C; Yan H; Gao N; Zhao J
Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):253-266. PubMed ID: 36519467
[TBL] [Abstract][Full Text] [Related]
35. The role of PAR4 in thrombin-induced thromboxane production in human platelets.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Teng CM
Thromb Haemost; 2003 Aug; 90(2):299-308. PubMed ID: 12888878
[TBL] [Abstract][Full Text] [Related]
36. The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets.
Nylander M; Osman A; Ramström S; Aklint E; Larsson A; Lindahl TL
Thromb Res; 2012 Apr; 129(4):e51-8. PubMed ID: 22283974
[TBL] [Abstract][Full Text] [Related]
37. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
Day JR; Haskard DO; Taylor KM; Landis RC
Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
[TBL] [Abstract][Full Text] [Related]
38. [Mechanism of action of protease-activated receptors 1 and 4 in platelet activation].
Han Y; Pasquet JM; Nurden A; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):495-8. PubMed ID: 14575544
[TBL] [Abstract][Full Text] [Related]
39. Activity of protease-activated receptors in the human submucous plexus.
Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.
Rigg RA; Healy LD; Chu TT; Ngo ATP; Mitrugno A; Zilberman-Rudenko J; Aslan JE; Hinds MT; Vecchiarelli LD; Morgan TK; Gruber A; Temple KJ; Lindsley CW; Duvernay MT; Hamm HE; McCarty OJT
Platelets; 2019; 30(1):126-135. PubMed ID: 30560697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
